A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.
These stocks can be a rollercoaster, and StockStory is here to guide you through the ups and downs. Keeping that in mind, here is one volatile stock that could deliver huge gains and two that might not be worth the risk.
Two Stocks to Sell:
Fortune Brands (FBIN)
Rolling One-Year Beta: 1.57
Targeting a wide customer base of residential and commercial customers, Fortune Brands (NYSE:FBIN) makes plumbing, security, and outdoor living products.
Why Do We Pass on FBIN?
- Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
- Inability to adjust its cost structure while its revenue declined over the last five years led to a 9 percentage point drop in the company’s operating margin
- Earnings per share have dipped by 6.5% annually over the past five years, which is concerning because stock prices follow EPS over the long term
Fortune Brands’s stock price of $38.50 implies a valuation ratio of 12.7x forward P/E. Read our free research report to see why you should think twice about including FBIN in your portfolio.
Myriad Genetics (MYGN)
Rolling One-Year Beta: 1.24
Founded in 1991 as one of the pioneers in translating genetic discoveries into clinical applications, Myriad Genetics (NASDAQ:MYGN) develops genetic tests that assess disease risk, guide treatment decisions, and provide insights across oncology, women's health, and mental health.
Why Are We Bearish on MYGN?
- Flat sales over the last two years suggest it must find different ways to grow during this cycle
- Earnings per share fell by 7.4% annually over the last five years while its revenue grew, partly because it diluted shareholders
- EBITDA losses may force it to accept punitive lending terms or high-cost debt
Myriad Genetics is trading at $4.11 per share, or 0.5x forward price-to-sales. Dive into our free research report to see why there are better opportunities than MYGN.
One Stock to Buy:
Paymentus (PAY)
Rolling One-Year Beta: 1.52
Founded in 2004 to simplify the complex world of bill payments, Paymentus (NYSE:PAY) provides a cloud-based platform that helps utilities, municipalities, and service providers automate billing and payment processes.
Why Are We Bullish on PAY?
- Market share has increased this cycle as its 39.5% annual revenue growth over the last two years was exceptional
- Additional sales over the last two years increased its profitability as the 47.8% annual growth in its earnings per share outpaced its revenue
At $30.80 per share, Paymentus trades at 31.2x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.